ACQUIRED FACTOR-VIII INHIBITOR ASSOCIATED WITH CHRONIC INTERFERON-ALPHA THERAPY

被引：0
|
作者：
STRICKER, RB
BARLOGIE, B
KIPROV, DD
机构：
[1] CALIF PACIFIC MED CTR,DEPT MED,DIV IMMUNOTHERAPY,SAN FRANCISCO,CA
[2] UNIV ARKANSAS MED SCI HOSP,DIV HEMATOL ONCOL,LITTLE ROCK,AR
来源：
JOURNAL OF RHEUMATOLOGY | 1994年 / 21卷 / 02期
关键词：
FACTOR VIII INHIBITOR; INTERFERON; DRUG REACTION; MULTIPLE MYELOMA; BONE MARROW TRANSPLANTATION;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Therapeutic use of interferon-alpha (IFN-alpha) has been associated with the development of a variety of autoimmune disorders. We describe a patient who received chronic treatment with IFN-alpha following autologous bone marrow transplantation for multiple myeloma. The patient developed an antibody inhibitor directed against factor VIII coagulant protein (FVIIIC) leading to a fatal hemorrhagic diathesis. The association between IFN-alpha therapy and autoimmune complications deserves wider recognition and further study.
引用
收藏
页码：350 / 352
页数：3
相关论文
共 50 条
  • [31] HAIRY-CELL LEUKEMIA AND FACTOR-VIII INHIBITOR - A CASE-REPORT
    KOMMINOTH, A
    DUFOUR, P
    BERGERAT, JP
    WIESEL, ML
    FALKENRODT, A
    OBERLING, F
    NOUVELLE REVUE FRANCAISE D HEMATOLOGIE, 1992, 34 (03): : 269 - 271
  • [32] Prediction of therapy response to interferon-alpha in chronic viral hepatitis-B by liver and hepatobiliary scintigraphy
    Caglar, M
    Sari, O
    Akcan, Y
    ANNALS OF NUCLEAR MEDICINE, 2002, 16 (07) : 511 - 514
  • [33] AN INHIBITOR OF ANTIHEMOPHILIC-FACTOR (FACTOR-VIII) IN AN 18-MONTH-OLD NONHEMOPHILIC CHILD
    STEIN, J
    RATNOFF, OD
    AMERICAN JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 1993, 15 (03): : 346 - 350
  • [34] EFFECTS OF INTERFERON-ALPHA THERAPY ON SERUM AND LIVER HBV DNA IN PATIENTS WITH CHRONIC HEPATITIS-B
    FEINMAN, SV
    BERRIS, B
    SOOKNANAN, R
    FERNANDES, B
    BOJARSKI, S
    DIGESTIVE DISEASES AND SCIENCES, 1992, 37 (10) : 1477 - 1482
  • [35] Prediction of therapy response to interferon-alpha in chronic viral hepatitis-B by liver and hepatobiliary scintigraphy
    Meltem Caglar
    Oktay Sari
    Yusuf Akcan
    Annals of Nuclear Medicine, 2002, 16 : 511 - 514
  • [36] ACQUIRED FACTOR-VIII-C INHIBITOR ANTIBODIES IN NONHEMOPHILIC PATIENTS
    SOHNGEN, D
    KUNTZ, BME
    HEINS, M
    SPECKER, C
    BACH, D
    BURK, M
    AUL, C
    SCHNEIDER, W
    INFUSIONSTHERAPIE UND TRANSFUSIONSMEDIZIN, 1995, 22 : 56 - 59
  • [37] Effect of the dose and duration of interferon-alpha therapy on the incidence of hepatocellular carcinoma in noncirrhotic patients with a nonsustained response to interferon for chronic hepatitis C
    Toyoda, H
    Kumada, T
    Nakano, S
    Takeda, I
    Sugiyama, K
    Kiriyama, S
    Sone, Y
    Tanikawa, M
    Hisanaga, Y
    Hayashi, K
    Honda, T
    ONCOLOGY, 2001, 61 (02) : 134 - 142
  • [38] LONGITUDINAL-STUDY OF ANTIBODIES AGAINST THYROID IN PATIENTS UNDERGOING INTERFERON-ALPHA THERAPY FOR HCV CHRONIC HEPATITIS
    CARELLA, C
    AMATO, G
    BIONDI, B
    ROTONDI, M
    MORISCO, F
    TUCCILLO, C
    CHIUCHIOLO, N
    SIGNORIELLO, G
    CAPORASO, N
    LOMBARDI, G
    HORMONE RESEARCH, 1995, 44 (03) : 110 - 114
  • [39] Acquired Factor VIII Inhibitor (Acquired Hemophilia A) Presenting as Spontaneous Blood-filled Scrotum
    Verma, Rajanshu
    Noack, Jill
    Vemuri, Radhakrishna
    Loehrke, Mark E.
    SOUTHERN MEDICAL JOURNAL, 2011, 104 (05) : 368 - 370
  • [40] A longitudinal study evaluating the effects of interferon-alpha therapy on cognitive and psychiatric function in adults with chronic hepatitis C
    Huckans, Marilyn
    Fuller, Bret
    Wheaton, Viva
    Jaehnert, Sarah
    Ellis, Carilyn
    Kolessar, Michael
    Kriz, Daniel
    Anderson, Jeanne Renee
    Berggren, Kristin
    Olavarria, Hannah
    Sasaki, Anna W.
    Chang, Michael
    Flora, Kenneth D.
    Loftis, Jennifer M.
    JOURNAL OF PSYCHOSOMATIC RESEARCH, 2015, 78 (02) : 184 - 192
12345